Ovchinnikova E.O., Kotov A.S., Panteleeva M.V., Zubanenko A.A. Analysis of the efficacy and safety of first- and second-line disease-modifying drugs for multiple sclerosis in treatment of pediatric multiple sclerosis. Russian Journal of Child Neurology. 2025;20(2):12-22. (In Russ.) https://doi.org/10.17650/2073-8803-2025-20-2-12-22
Editor-in-Chief
Petrukhin A.S.
Email this article (Login required)
Email the author (Login required) Full name: Limited liability company “Publishing house “ABV press”
Abbreviated name: “PH “ABV press” Co. Ltd
Name in English: Publishing house “ABV press” Co. Ltd
Legal address: build. 2, 2 Starokashirskoe Shosse, room 6A section I, municipal district Nagatino-Sadovniki, Moscow, 115201, Russia
Actual address: build. 15, 24 Kashirskoe Shosse, Research Institute of Carcinogenesis, Moscow, Russia
Postal address: Publishing house “ABV press” Co. Ltd, PO box 35, Moscow, 109443, Russia
Main state registration number: 1097746241757
TIN: 7724705329
Tel./fax: +7 (499) 929-96-19
Processing of personal data
